3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across Canada Toronto, Ontario--(Newsfile Corp. - November 22, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the national launch of InsuJet™ in Canada. The launch began on November 15, in conjunction with the commemoration of... Read More

Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that its shareholders have approved Sol-Millennium Medical HK Limited (" Sol-M ") and Nature Health Development (Hong Kong) Co. Limited (" Nature Health ") as new Control Persons (as defined... Read More

5,000 InsuJet devices to be delivered to the UK Toronto, Ontario--(Newsfile Corp. - October 25, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce a strategic partnership with EziAutoJector ® Limited (" EziAutoJector "), a company domiciled in Jersey, United Kingdom, for the delivery of... Read More

Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, further to its press release dated August 15, 2024, Sol-Millennium Medical HK Limited (" Sol-M ") and Nature Health Development (Hong Kong) Co. Limited (" Nature Health ") have... Read More

Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of Q2 2024 Financial Results and is pleased to provide updates on commercial progress and its proposed private placement of up to $10 million secured convertible debentures (the "... Read More

Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce voting results from the annual and special meeting of the Company's shareholders (the " Meeting ") held on August 20, 2024. At the Meeting, shareholders voted in favour of all resolutions... Read More

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, announces that price protection has expired for its proposed non-brokered private placement (the " Offering ") of up to $10,000,000 principal amount secured convertible debentures (the " Convertible Debentures ")... Read More

Toronto, Ontario--(Newsfile Corp. - July 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Science Link, the exclusive distributor of the Insujet TM in Mexico has placed an additional order for 4,500 Insujet injectors to support channel expansion and demand growth in the Mexico... Read More

Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce its intention to complete a non-brokered private placement (the " Offering ") of up to $10,000,000 principal amount secured convertible debentures (the " Convertible Debentures "). The... Read More

Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that it has formed a three-way partnership with Wholehealth Pharmacy Partners (" Wholehealth ") and Sol-Millennium Medical Group (" Sol-M ") to develop retail pharmacy training materials aimed at... Read More

Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of June 26, 2024, the commercial teams of Sol-Millennium TM Medical Inc. (" Sol-M TM ") in Brazil have successfully completed the sales and in-depth clinical training required for InsuJet... Read More

Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Rosheta for Medicines and Medical Supplies (" Rosheta "), NuGen's exclusive distributor in Yemen, has placed a second order to fulfill growing demand in the country. The order includes 1,100... Read More

Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, is pleased to announce that Sol-Millennium TM Medical Inc. (" Sol-M ") has placed its initial purchase order of 3,832 InsuJet TM injectors plus consumables to fulfill the first pharmacy orders received by... Read More

Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, announces the release Q1 2024 Financial Results and is pleased to provide an update on the strong commercial progress made year to date. Q1 Financials in Line with Management Expectations Financial Results for the Q1... Read More

Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") announces that it has agreed to settle an aggregate of €275,000 of indebtedness owed to Care4Pharma B.V. (" Care4Pharma "), an arm's length creditor (the " Creditor "), with respect to monies owed pursuant to the share purchase agreement between the Company and Care4Pharma dated June 30, 2021 (the "... Read More

Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of January 30 th , 2024, Sol-Millennium Medical Inc.'s (" Sol-M ") global sales & marketing team has now completed their in-depth clinical training of NuGen's needle-free InsuJet™... Read More

Toronto, Ontario--(Newsfile Corp. - January 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that its distribution partner in Mexico, Science-Link Trading SAPI de CV (" Science-Link ") has expanded their distribution network to now include Argentina, Chile, Costa Rica and Peru.... Read More

Toronto, Ontario--(Newsfile Corp. - December 19, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of December 17, 2023, Verrue Consulting Group BV (" Verrue "), a limited liability company incorporated under the laws of Belgium, became an official distributor for NuGen's... Read More

Toronto, Ontario--(Newsfile Corp. - December 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, as of December 12, 2023, Advance Medical Life Co. Ltd. (" Advance Medical "), a limited liability company domiciled in Bangkok, Thailand, became the exclusive distributor for NuGen's... Read More

Second Bulk Sale for InsuJet(TM) Now Paid in Full Toronto, Ontario--(Newsfile Corp. - November 13, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce the Mexican government has completed the registration of NuGen's needle-free InsuJet™ injection device for sale throughout the country as a medical device. In May 2023, NuGen received its first bulk purchase order from... Read More

www.insujet.com - a diabetic e-commerce store Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the official launch on Shopify of its diabetic's lifestyle subscription business at www.insujet.com offering diabetics the ability to purchase our... Read More

Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that Mr. Ian Heynen has commenced his role as the Company's new Chief Executive Officer focusing his attention on fully commercializing the Company with sales and manufacturing capabilities that... Read More

Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle free devices to administer therapeutics subcutaneously, is pleased to announce it has appointed Mr. Ian Heynen as the Company's new Chief Executive Officer, effective November 1, 2023. Mr. Heynen is recognized in the med-tech industry as a top-performing industry... Read More

Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle free devices to administer therapeutics subcutaneously, today presented new data from a preliminary trial that semaglutide (Ozempic®) is chemically stable after it is administered through NuGen's InsuJet™ needle-free injection device. "Today's discovery paves the way for... Read More

Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to report it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet™ injector device and consumables to SC Trustmed SRL (" Trustmed ") in Romania as previously announced on June 12 th , 2023. The sale, although small in size, was completed earlier... Read More

Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to report it has received $1,302,000 through the exercise of 25,290,000 warrants having an exercise price of $0.05 expiring February 14, 2025, and 750,000 options at $0.05 expiring December 13, 2027. " The early exercise of the 5-cent option and warrants has improved the capitalization... Read More

Toronto, Ontario--(Newsfile Corp. - September 5, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen "), is pleased to announce that Richard Buzbuzian, NuGen's President, CEO and Director, and Karen Dunlap, Chief Customer Officer and Director, are scheduled to present at the 2023 Kinvestor Days Virtual Conference on September 20, 2023, at 9:00 am PT (12:00 pm ET). More details below. This year's... Read More

Toronto, Ontario--(Newsfile Corp. - August 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to provide shareholders the following corporate update. Corporate mission: NuGen's mission is to reduce the daily burden of diabetes care by providing a needle-free insulin injection device and supplies tailored to each diabetic's personal needs with our InsuJet™ device which is approved for... Read More

Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce it has entered into a distribution agreement for its needle-free InsuJet™ medical device and consumables with Sol-Millennium Medical Inc. (" Sol-M ") of Chicago, Illinois USA, for a term of five years which NuGen estimates the value at approximately $204 million dollars with... Read More

Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce that it has delivered its first shipment of InsuJet™ devices and consumables to Reliance Medical Ltd., the Company's UK distributor and 3PL partner in the UK. NuGen further announces their attendance at the Diabetes Professional Care conference taking place on November 15 th and... Read More

National Health System (NHS) of the UK lists InsuJet(TM) in its online tariff list Toronto, Ontario--(Newsfile Corp. - June 23, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce that it has received payment for the first shipment of InsuJet™, our needle-free insulin delivery system, to its Mexican contractor, Science-Link Trading SAPI de CV. 500 InsuJet™ devices will ship... Read More

Toronto, Ontario--(Newsfile Corp. - June 16, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to report it has sold 800 units of the Company's needle-free InsuJet™ injector device and consumables to Rosheta for Medicines and Medical Supplies in Yemen. The Company anticipates further sales to Rosheta for Medicines and Medical Supplies and will report such sales as they occur. InsuJet™... Read More

Beginning with the United Kingdom Toronto, Ontario--(Newsfile Corp. - June 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce it has engaged Porter Media, a growth marketing team that specializes in scaling online businesses, to develop product awareness and grow sales of the Company's needle-free injection device, InsuJet™ which is approved for sale as a medical device... Read More

Toronto, Ontario--(Newsfile Corp. - June 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to report it has sold 500 units of the Company's needle-free InsuJet™ injector device and consumables to Trustmed SRL in Romania. The Company anticipates further sales from Trustmed SRL and will report such sales as they occur. InsuJet™ is registered and authorized for use in Romania as a... Read More

Reliance Medical Group - UK Distributor, 3PL Partner Toronto, Ontario--(Newsfile Corp. - June 9, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce InsuJet™ is now registered for supply through the NHS Drug Tariff. Reliance Medical Group (" Reliance Medical ") has been appointed as our 3PL partner and distributor for NuGen in the United Kingdom. Reliance Medical is a leading... Read More

Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce it has engaged Dsrupt Media Inc. (" DSRUPT ") to develop product awareness and grow sales of NuGen's needle-free InsuJet™ medical device, targeting diabetics around the world. InsuJet™ is approved for sale as a medical device in 42 countries. " We were drawn to the talent at DSRUPT... Read More

Toronto, Ontario--(Newsfile Corp. - June 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce it has received its first bulk purchase order from Science-Link Trading SAPI de CV (" Science-Link "), a company in Mexico, for the Mexican market for 500 units of the Company's needle-free InsuJet™ injector device. The initial bulk purchase order for the 500 InsuJet™ devices is to... Read More

Toronto, Ontario--(Newsfile Corp. - May 30, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce that it is hosting an investor lunch presentation on June 15 th at Modus Restaurant, located at 145 King Street West, Toronto, Ontario M5H 1J8 at 12:00 p.m. EDT, limited to 70 attendees. " Maintaining the philosophy of treating our investors as customers, I cordially invite... Read More

Toronto, Ontario--(Newsfile Corp. - May 29, 2023) - NuGen Medical Devices Inc . (TSXV: NGMD) (" NuGen " or the " Company ") announces that, further to its press release dated February 28, 2023, it has entered into an amended and restated agreement (the " Agreement ") dated May 29, 2023 with bullVestor Medien GmbH (" bullVestor "), an arm's-length party to the Company, to provide marketing services to the Company for a period... Read More

Toronto, Ontario--(Newsfile Corp. - May 18, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (" NuGen " or the " Company ") announces that it has closed a non-brokered private placement of units (the " Offering ") through the issuance of 2,500,000 units (each a " Unit ") at a price of $0.18 per Unit for aggregate gross proceeds of $450,000. " As a result of strong demand, we elected to accommodate those that missed the... Read More

Toronto, Ontario--(Newsfile Corp. - April 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (" NuGen " or the " Company ") announces that it has closed its non-brokered private placement of units (the " Offering ") through the issuance of 22,222,222 units (each a " Unit ") at a price of $0.18 per Unit for aggregate gross proceeds of $4,000,000. " Strong investor demand from new and existing shareholders has provided NuGen... Read More

Toronto, Ontario--(Newsfile Corp. - April 21, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company ") is pleased to announce that, further to its press release of March 31, 2023, its previously announced non-brokered private placement of units (each, a " Unit ") at a price of $0.18 per Unit has been upsized to 22,222,222 Units for aggregate gross proceeds of $4,000,000 (the " Offering "). Net proceeds raised from... Read More

Toronto, Ontario--(Newsfile Corp. - April 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") announces it has engaged Basic Pharma Technologies, a pharmaceutical company located in the Netherlands, to perform an assessment and feasibility study, which will include validation testing of semaglutide if administered using NuGen's needle free injection device, InsuJet™. Semaglutide is the drug... Read More

Toronto, Ontario--(Newsfile Corp. - April 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce it is hosting its first Investors Presentation night in Vaughan, Ontario on April 20, 2023 at 7:00 p.m. EST. "We have always maintained the philosophy of treating our Investor's as customers and cordially invite all interested parties to attend our event on April 20, 2023,"... Read More

Toronto, Ontario--(Newsfile Corp. - April 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce the appointment of Louise Cresswell as the Commercial Lead for the United Kingdom. Ms. Cresswell has an extensive background working in the UK health sector both as a registered nurse and in commercial, sales and marketing roles with international manufacturers and suppliers of... Read More

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") announces it intends to complete a non-brokered private placement of up to $3,600,000 through the issuance of up to 20,000,000 units (the " Units ") in the capital of the Company at a price of $0.18 per Unit (the " Offering "). Gross proceeds of the Offering will be used for working capital and general... Read More

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce its new B2C online subscription-based business to be offered at www.insujet.com will be available to consumers in the coming weeks ahead. By utilizing fulfillment centers across Europe and Canada, we ensure fast delivery for all purchases that can be made via smartphone or our... Read More

Engages With Sol-Millennium Toronto, Ontario--(Newsfile Corp. - March 27, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to report that the Company's InsuJet™ needle-free injection device is actively sold in 11 countries through NuGen's distributor and wholesale network. InsuJet™ will soon be readily provided to end-customers throughout Europe through conventional channels, such as... Read More

Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce that the Board of Directors has re-appointed Ms. Veronique Laberge as Chief Financial Officer and Corporate Secretary of the Company. "I am excited to return into the CFO role at NuGen and work with the new management team to help the company continue executing its strategic... Read More

Results Provide over 40% Faster Uptake of Insulin Toronto, Ontario--(Newsfile Corp. - March 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake [1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands. Studies... Read More

Toronto, Ontario--(Newsfile Corp. - February 28, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director. "I was approached by NuGen's new CEO, Richard Buzbuzian, who I had tremendous success with having built Drone Delivery Canada together from inception to then being named in 2021... Read More

Toronto, Ontario--(Newsfile Corp. - February 22, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company ") is pleased to announce that the Board of Directors has appointed Richard Buzbuzian as President, CEO and Director. "InsuJet™, our needle-free injection device has tremendous sales opportunity globally and is approved for sale in 42 countries with active sales distribution agreements in 11. I look to complement... Read More

Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company ") announces that it has closed its previously announced (see press release dated January 26, 2023) non-brokered private placement of units (the " Offering ") through the issuance of 50,000,000 units (each a " Unit ") at a price of $0.05 per Unit for aggregate gross proceeds of $2,500,000. Each Unit is comprised of... Read More

Toronto, Ontario--(Newsfile Corp. - January 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company ") announces that it has closed its previously announced non-brokered private placement of units as described in its press release dated December 28, 2022 for total aggregate proceeds of $125,000. No additional tranches will be completed. The proceeds will be used by the Company for corporate and general working... Read More

TORONTO, ON / ACCESSWIRE / December 28, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (OTCQB:NGMDF) ("NuGen'' or the "Company") announces that it has closed the first tranche of a non-brokered private placement through the issuance of 2,500,000 units (" Units ") at a price of $0.05 per Unit for gross proceeds of $125,000 (the " Offering "). Each Unit is comprised of one common share (" Common Share ") of the Company and one... Read More

TORONTO, ON / ACCESSWIRE / December 15, 2022 / The Board of directors of NuGen Medical Devices Inc. (TSXV:NGMD) (OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, announces the departure of Mr. Michael Wright, President and Chief Executive Officer, effective immediately. Mr. Wright remains a director and a shareholder of the Company and will assist with the management transition. The Company... Read More